Shikiar Asset Management Inc Uro Gen Pharma Ltd. Transaction History
Shikiar Asset Management Inc
- $372 Million
- Q2 2024
A detailed history of Shikiar Asset Management Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 10,750 shares of URGN stock, worth $133,085. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,750
Previous 33,250
67.67%
Holding current value
$133,085
Previous $499,000
63.93%
% of portfolio
0.05%
Previous 0.15%
Shares
19 transactions
Others Institutions Holding URGN
# of Institutions
120Shares Held
39.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.56MShares$44 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$40.9 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$38.2 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.91MShares$36 Million12.93% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$30.3 Million0.11% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $282M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...